Gland Pharma Limited

GLAND

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Jun 20261,287

    Quarter₹ croreYoY
    Jun 20241,012+14.5%
    Sept 20241,063+5.2%
    Dec 20241,011-7.9%
    Mar 20251,030-12.3%
    Jun 20251,039+2.6%
    Sept 20251,074+1.1%
    Dec 20251,178+16.5%
    Mar 20261,262+22.4%
    Jun 20261,287+23.9%
  • ₹ crore

    Jun 202659

    Quarter₹ crore
    Jun 202448
    Sept 202458
    Dec 202465
    Mar 202544
    Jun 202555
    Sept 202583
    Dec 202560
    Mar 2026106
    Jun 202659
  • ₹ crore

    Jun 20261,345

    Quarter₹ crore
    Jun 20241,061
    Sept 20241,121
    Dec 20241,076
    Mar 20251,074
    Jun 20251,094
    Sept 20251,157
    Dec 20251,238
    Mar 20261,368
    Jun 20261,345
  • Cost structure
  • ₹ crore

    Jun 2026144

    Quarter₹ crore
    Jun 2024108
    Sept 2024106
    Dec 2024105
    Mar 2025120
    Jun 2025128
    Sept 2025132
    Dec 2025134
    Mar 2026134
    Jun 2026144
  • ₹ crore

    Jun 2026858

    Quarter₹ crore
    Jun 2024760
    Sept 2024741
    Dec 2024682
    Mar 2025683
    Jun 2025731
    Sept 2025748
    Dec 2025801
    Mar 2026803
    Jun 2026858
  • Exceptional items and tax
  • ₹ crore

    Jun 2026488

    Quarter₹ crore
    Jun 2024300
    Sept 2024380
    Dec 2024394
    Mar 2025391
    Jun 2025362
    Sept 2025409
    Dec 2025412
    Mar 2026565
    Jun 2026488
  • ₹ crore

    Jun 2026123

    Quarter₹ crore
    Jun 202477
    Sept 202498
    Dec 202499
    Mar 2025101
    Jun 202593
    Sept 2025107
    Dec 2025105
    Mar 2026144
    Jun 2026123
  • Profit
  • ₹ crore

    Jun 2026364

    Quarter₹ croreYoY
    Jun 2024223+18.8%
    Sept 2024282+9.4%
    Dec 2024295+6.6%
    Mar 2025290-9.8%
    Jun 2025269+20.8%
    Sept 2025302+7.2%
    Dec 2025308+4.3%
    Mar 2026420+45.0%
    Jun 2026364+35.3%
  • Per share
  • ₹ per share

    Jun 202622.11

    Quarter₹ per share
    Jun 202413.53
    Sept 202417.10
    Dec 202417.91
    Mar 202517.60
    Jun 202516.34
    Sept 202518.33
    Dec 202518.68
    Mar 202625.52
    Jun 202622.11
₹ croreJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Income
1,0121,0631,0111,0301,0391,0741,1781,2621,287
Revenue YoY+14.5%+5.2%-7.9%-12.3%+2.6%+1.1%+16.5%+22.4%+23.9%
4858654455836010659
1,0611,1211,0761,0741,0941,1571,2381,3681,345
Cost structure
108106105120128132134134144
760741682683731748801803858
Exceptional items and tax
300380394391362409412565488
77989910193107105144123
Profit
223282295290269302308420364
Net profit YoY+18.8%+9.4%+6.6%-9.8%+20.8%+7.2%+4.3%+45.0%+35.3%
Per share
13.5317.1017.9117.6016.3418.3318.6825.5222.11

Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.